Healthcare provider profile · identity verified

Benjamin T Agana, MD

Physical Medicine and Rehabilitation · SHENANDOAH, TX · NPI 1063455111

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	219	193
Pantoprazole Sodium	Pantoprazole Sodium	169	152
Gabapentin	Gabapentin	151	129
Levothyroxine Sodium	Levothyroxine Sodium	143	124
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	117
Furosemide	Furosemide	135	125
Eliquis	Apixaban	122	110
Losartan Potassium	Losartan Potassium	118	104
Tamsulosin Hcl	Tamsulosin Hcl	111	100
Metoprolol Succinate	Metoprolol Succinate	105	98
Clopidogrel	Clopidogrel Bisulfate	97	88
Carvedilol	Carvedilol	95	86
Nifedipine Er	Nifedipine	93	85
Tramadol Hcl	Tramadol Hcl	92	62
Amlodipine Besylate	Amlodipine Besylate	89	87
Metoprolol Tartrate	Metoprolol Tartrate	82	76
Midodrine Hcl	Midodrine Hcl	64	55
Amiodarone Hcl	Amiodarone Hcl	62	56
Metformin Hcl	Metformin Hcl	60	51
Rosuvastatin Calcium	Rosuvastatin Calcium	57	51
Potassium Chloride	Potassium Chloride	56	52
Sertraline Hcl	Sertraline Hcl	52	46
Lisinopril	Lisinopril	49	48
Famotidine	Famotidine	48	47
Prednisone	Prednisone	45	34
Duloxetine Hcl	Duloxetine Hcl	44	41
Pregabalin	Pregabalin	43	38
Mirtazapine	Mirtazapine	42	40
Montelukast Sodium	Montelukast Sodium	42	36
Donepezil Hcl	Donepezil Hcl	41	36
Latanoprost	Latanoprost	39	36
Escitalopram Oxalate	Escitalopram Oxalate	37	30
Buspirone Hcl	Buspirone Hcl	35	30
Ezetimibe	Ezetimibe	34	29
Trazodone Hcl	Trazodone Hcl	34	34
Hydralazine Hcl	Hydralazine Hcl	31	30
Levetiracetam	Levetiracetam	31	28
Quetiapine Fumarate	Quetiapine Fumarate	30	25
Finasteride	Finasteride	29	26
Lantus	Insulin Glargine,hum.Rec.Anlog	28	27
Spironolactone	Spironolactone	28	27
Omeprazole	Omeprazole	27	25
Allopurinol	Allopurinol	26	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	23
Fluoxetine Hcl	Fluoxetine Hcl	24	20
Oxycodone Hcl	Oxycodone Hcl	23	19
Ropinirole Hcl	Ropinirole Hcl	23	21
Carbidopa-Levodopa	Carbidopa/Levodopa	22	17
Sucralfate	Sucralfate	22	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	21
Methocarbamol	Methocarbamol	21	21
Acetaminophen-Codeine	Acetaminophen With Codeine	20	20
Bupropion Xl	Bupropion Hcl	20	18
Breo Ellipta	Fluticasone/Vilanterol	18	18
Cefdinir	Cefdinir	18	18
Hydrochlorothiazide	Hydrochlorothiazide	18	18
Jardiance	Empagliflozin	18	16
Torsemide	Torsemide	18	18
Xarelto	Rivaroxaban	18	18
Memantine Hcl	Memantine Hcl	17	15
Metformin Hcl Er	Metformin Hcl	17	16
Pravastatin Sodium	Pravastatin Sodium	17	16
Timolol Maleate	Timolol Maleate	17	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	15
Meloxicam	Meloxicam	16	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	14
Simvastatin	Simvastatin	16	15
Tizanidine Hcl	Tizanidine Hcl	16	14
Oxybutynin Chloride Er	Oxybutynin Chloride	15	13
Brimonidine Tartrate	Brimonidine Tartrate	14	13
Farxiga	Dapagliflozin Propanediol	14	14
Fluticasone Propionate	Fluticasone Propionate	14	13
Lactulose	Lactulose	14	14
Lamotrigine	Lamotrigine	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	13
Warfarin Sodium	Warfarin Sodium	14	12
Bumetanide	Bumetanide	13	11
Doxycycline Monohydrate	Doxycycline Monohydrate	13	12
Fenofibrate	Fenofibrate Nanocrystallized	13	13
Levofloxacin	Levofloxacin	13	13
Megestrol Acetate	Megestrol Acetate	13	11
Tradjenta	Linagliptin	13	13
Bupropion Hcl	Bupropion Hcl	12	12
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	11
Baclofen	Baclofen	11	11
Digoxin	Digoxin	11	11
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error